GlassScriptPhysician profile
Louis Stein
NPI 1356503148
$5,696.68
in general payments reported to CMS, 2019-2025
16 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $315 · 2021: $1,107 · 2022: $1,586 · 2023: $934 · 2024: $674 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070 · Travel and Lodging: $38.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.84 |
| Travel and Lodging | $38.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,620.20 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $1,812.67 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Inspiris Resilia Aortic Valve |
| Medtronic, INC. | $416.95 | 2021-2024 | Corevalve Evolut R |
| Atricure, INC. | $219.25 | 2020-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Livanova USA, INC. | $181.40 | 2019 | |
| Abbott Laboratories | $146.35 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Depuy Synthes Sales INC. | $73.12 | 2020 | |
| Medical Device Business Services, INC. | $40.00 | 2020 | |
| Baxter Healthcare | $38.63 | 2019-2020 | |
| Amgen INC. | $32.56 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.30 | 2022 | |
| Avanos Medical | $22.88 | 2019 | |
| Elutia, INC. | $21.69 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.80 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.36 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.